HDAC9 and ovarian neoplasm: The observation that overexpression of miR-302b increased the sensitivity of ovarian tumor cells to cisplatin, together with the reported tissue specificity of miRNAs [38], raises the possibility of using this miRNA to modulate DNA-damaging drug sensitivity and avoiding HDAC inhibitor toxicity.